Cargando…

Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients

BACKGROUND: The KDIGO Clinical Practice Guidelines for Glomerulonephritis recommended tacrolimus as an alternative regimen for the initial therapy for Idiopathic membranous nephropathy (IMN), however, large observational studies evaluating tacrolimus treatment in IMN remains rare. METHODS: A total o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Hua-Zhang, Liu, Lei, Liang, Shao-Shan, Shi, Jing-Song, Zheng, Chun-Xia, Hou, Qing, Lu, Ying-Hui, Le, Wei-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216560/ https://www.ncbi.nlm.nih.gov/pubmed/28056860 http://dx.doi.org/10.1186/s12882-016-0427-z

Ejemplares similares

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
por: Cui, W., et al.
Publicado: (2017)

Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019)

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
por: Shang, Shun-Lai, et al.
Publicado: (2018)

Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study
por: Liu, Shanshan, et al.
Publicado: (2015)

Effect of Nephritis Rehabilitation Tablets combined with tacrolimus in treatment of idiopathic membranous nephropathy
por: Lv, Wei, et al.
Publicado: (2021)

Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Clinical efficacy and safety of different tacrolimus concentrations for the treatment of patients with idiopathic membranous nephropathy
por: Wang, Qi, et al.
Publicado: (2021)

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
por: Liang, Qian, et al.
Publicado: (2017)

Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
por: Zhang, Chengning, et al.
Publicado: (2020)

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2019)

Electron-Dense Deposition Patterns and the Outcomes of Nephrotic Idiopathic Membranous Nephropathy Treated with Tacrolimus in Chinese Adults
por: Xiang, Xin, et al.
Publicado: (2021)

Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials
por: Huang, Haiting, et al.
Publicado: (2021)

Tacrolimus-induced epilepsy with primary membranous nephropathy: A case report
por: Yang, Yan, et al.
Publicado: (2021)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Partners in crime: MicroRNA408 and peptide miPEP408 negatively regulate arsenic and low sulfur tolerance
por: Ku, Yee-Shan
Publicado: (2023)

Idiopathic membranous nephropathy in children: A case report
por: Cui, Kun-Hua, et al.
Publicado: (2022)

Advances of the experimental models of idiopathic membranous nephropathy
por: Jiang, Han Xue, et al.
Publicado: (2020)

Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study
por: Chen, Xian, et al.
Publicado: (2023)

The Calcineurin Inhibitor Tacrolimus Reduces Proteinuria in Membranous Nephropathy Accompanied by a Decrease in Angiopoietin-Like-4
por: Peng, Lei, et al.
Publicado: (2014)

At R407/R408
Publicado: (1974)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
por: Nikolopoulou, Aikaterini, et al.
Publicado: (2019)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

Idiopathic membranous nephropathy with renal amyloidosis: A case report
por: Wang, Yue, et al.
Publicado: (2022)

Evaluating Efficacy and Safety of Tacrolimus Treatment in Membranous Nephropathy: Results of a Retrospective Study of 182 Patients
por: Liang, Shuang, et al.
Publicado: (2023)

Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome
por: Chen, Tianxin, et al.
Publicado: (2021)

Variants in the Promoter Region of HLA-DQA1 were Associated with Idiopathic Membranous Nephropathy in a Chinese Han Population
por: Qin, Xiao-Song, et al.
Publicado: (2017)

Patient Age and the Prognosis of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014)

Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
por: Kennedy, Claire, et al.
Publicado: (2013)

Idiopathic Membranous Nephropathy and Treatment Related Complications
por: Uncanin, Snezana, et al.
Publicado: (2020)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Urinary peptidomics reveals proteases involved in idiopathic membranous nephropathy
por: Lin, Baoxu, et al.
Publicado: (2021)

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy
por: Wang, Yu, et al.
Publicado: (2017)

Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction
por: Wang, Peiheng, et al.
Publicado: (2023)

Research Progress in the Treatment of Idiopathic Membranous Nephropathy using Traditional Chinese Medicine
por: Lang, Rui, et al.
Publicado: (2020)

High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation
por: Buxeda, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u3kbp8luqhp691olgr4nvf197u